Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE (SHP)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 06/20 02:57:15 pm
4021.25 GBp   +1.09%
12:48pSHIRE : Form 8.5 (EPT/NON-RI)- Shire Plc
PU
12:18pSHIRE : Form 8.5 Shire Plc
PU
12:08pSHIRE : Form 8.5 (EPT/RI)- Shire plc
PU
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

SHIRE : Ex-dividend day for final dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2018 CEST

A final dividend is removed today from Shire's share.



© Factset 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIRE
01:56pStock Performance Review on Sesen Bio and Three Other Biotech
AC
12:48pSHIRE : Form 8.5 (EPT/NON-RI)- Shire Plc
PU
12:18pSHIRE : Form 8.5 Shire Plc
PU
12:08pSHIRE : Form 8.5 (EPT/RI)- Shire plc
PU
11:13aSHIRE : Form 8.5 (EPT/RI) - SHIRE PLC
PU
08:48aSHIRE : Form 8.3 - Takeda Pharmaceutical Company Limited
PU
08:18aSHIRE : Form 8.3 - Shire PLC
PU
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
06/19SHIRE : Form 8.3 - shire plc - amendment
PU
06/19SHIRE : Form 8.5 (EPT/NON-RI) - SHIRE PLC
PU
More news
News from SeekingAlpha
06/19Merger Arbitrage Mondays - June 18, 2018 
06/15Key events next week - healthcare 
06/12Avrobio Aims For $75 Million U.S. IPO 
06/12Nash players perk up on Galmed surge 
06/12Can The Shire Buyout Be Stopped? 
Financials ($)
Sales 2018 15 466 M
EBIT 2018 5 653 M
Net income 2018 2 899 M
Debt 2018 15 004 M
Yield 2018 0,70%
P/E ratio 2018 16,73
P/E ratio 2019 13,98
EV / Sales 2018 4,10x
EV / Sales 2019 3,74x
Capitalization 48 412 M
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Technical analysis trends SHIRE
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 63,5 $
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Thomas J. W. Dittrich Chief Financial Officer & Director
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE2.00%48 412
JOHNSON & JOHNSON-13.17%325 398
PFIZER-0.17%211 520
NOVARTIS-8.25%188 977
ROCHE HOLDING LTD.-14.38%182 331
MERCK AND COMPANY8.46%164 082